Review reviewCritical

CVE-2026-24164

NVIDIA BioNeMo Framework, bionemo framework

NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CVSS
9.8
EPSS
0.47%
38.4% percentile
CISA KEV
Not listed
Published
2026.04.01
PRIORITY ASSESSMENT

Review review

The CVSS severity warrants an early asset and exposure review.

Known exploitationNot established by KEV
Exploit probability0.47%
Technical severityCVSS 9.8

Vulnerability overview

NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

Affected product and versions

Product
NVIDIA BioNeMo Framework, bionemo framework
Affected versions
>= All versions that do not include commit f2c2b14, < 2026-01-21
Fixed versions
2026-01-21

Recommended response sequence

Confirm exposure before applying a vendor-supported change.

Full remediation guide
  1. 1
    Identify

    Confirm that NVIDIA BioNeMo Framework, bionemo framework and an affected version are present.

  2. 2
    Prioritize

    Combine exploitation signals with asset exposure and business criticality.

  3. 3
    Remediate

    Follow the vendor advisory or supported update path and preserve rollback options.

  4. 4
    Verify

    Recheck the version, service health, access paths, and relevant logs.

Technical data

CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CWE
CWE-502
CVE-2026-24164 — NVIDIA BioNeMo Framework, bionemo framework | SECUFOCUS NOW